WeightWatchers 2015 Annual Report Download - page 82

Download and view the complete annual report

Please find page 82 of the 2015 WeightWatchers annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 159

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159

WEIGHT WATCHERS INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE FISCAL YEARS ENDED
(IN THOUSANDS)
January 2,
2016
January 3,
2015
December 28,
2013
(52 Weeks) (53 Weeks) (52 Weeks)
Operating activities:
Net income ...................................................... $ 32,779 $117,733 $ 202,742
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization ................................... 53,171 49,234 47,909
Amortization of deferred financing costs .......................... 6,886 9,305 7,672
Impairment of intangible and long-lived assets ...................... 2,455 652 5,426
Share-based compensation expense ............................... 24,771 10,533 4,255
Deferred tax provision ......................................... 12,098 29,099 34,358
Allowance for doubtful accounts ................................. (446) 99 596
Reserve for inventory obsolescence .............................. 7,593 11,822 9,580
Foreign currency exchange rate loss .............................. 1,526 2,984 659
Gain on Brazil acquisition ...................................... 0 (10,540) 0
Loss on disposal of assets ...................................... 0 171 1,417
(Gain) loss on early extinguishment of debt ........................ (12,667) 0 21,685
Other items, net .............................................. 0 (184) 0
Changes in cash due to:
Receivables ................................................. 1,571 3,777 345
Inventories .................................................. (3,055) (3,218) (2,226)
Prepaid expenses ............................................. (18,284) 1,341 1,037
Accounts payable ............................................. (13,930) 7,807 (3,607)
UK self-employment liability ................................... 0 0 (7,272)
Accrued liabilities ............................................ (30,906) 10,361 4,988
Deferred revenue ............................................. 1,256 (7,915) (10,521)
Income taxes ................................................ (10,003) (1,442) 4,473
Cash provided by operating activities ............................. 54,815 231,619 323,516
Investing activities:
Capital expenditures .............................................. (3,952) (9,097) (40,657)
Capitalized software expenditures .................................... (32,307) (42,589) (21,277)
Cash paid for acquisitions .......................................... (3,112) (16,678) (83,825)
Other items, net .................................................. (936) (628) 411
Cash used for investing activities (40,307) (68,992) (145,348)
Financing activities:
Proceeds from new term loans ....................................... 0 0 2,400,000
Borrowings on revolver ............................................ 48,000 0 70,000
Payments on long-term debt ........................................ (158,113) (30,000) (2,488,364)
Payment of dividends ............................................. (42) (80) (29,571)
Proceeds from the sale of common stock, net of fees ..................... 41,475 0 0
Deferred financing costs ........................................... 0 0 (44,817)
Proceeds from stock options exercised ................................ 95 658 16,187
Tax benefit of restricted stock units vested and stock options exercised ...... 0 1 2,132
Cash used for financing activities (68,585) (29,421) (74,433)
Effect of exchange rate changes on cash and cash equivalents and other .......... (5,609) (6,551) 607
Net (decrease) increase in cash and cash equivalents ......................... (59,686) 126,655 104,342
Cash and cash equivalents, beginning of fiscal year .......................... 301,212 174,557 70,215
Cash and cash equivalents, end of fiscal year ............................... $241,526 $301,212 $ 174,557
The accompanying notes are an integral part of the consolidated financial statements.
F-7